探索对外围神经病变的影响:叙述性综述
Advances in mind-body medicine
|June 5, 2024
概括
可以帮助管理周围神经病变症状,包括糖尿病和化疗诱导的类型. 然而,可能会发生不良事件,需要由合格的医生进行监督,以确保安全练习.
科学领域:
- 神经学 神经学
- 综合医学是一个整体的医学.
- 物理疗法物理治疗
背景情况:
- 外围神经病变是一种影响外围神经系统的多种疾病.
- 虽然对许多疾病的益处是众所周知的,但它对外围神经病变的影响尚未得到充分研究.
研究的目的:
- 系统地审查对外围神经病变的影响.
- 为了识别与相关的潜在不良事件,用于外围神经病变.
主要方法:
- 在PubMed/Medline进行了系统的文献搜索,截至2024年3月5日.
- 包括的研究评估了后症状改善和外围神经病变的临床指标.
- 在最初选的101篇文章中,选出了16篇文章.
主要成果:
- 显示出作为糖尿病外围神经病变,化疗诱导的外围神经病变以及腰椎间盘,吉兰-巴雷综合征和手腕道综合征的神经病变的辅助疗法的潜力.
- 报告了一些不良事件,包括光眼神经病变,坐骨神经病变和急性运动功能丧失.
结论:
- 可能是对外围神经病管理的有前途的辅助疗法.
- 需要进一步进行大规模研究,采用标准化干预措施和客观措施.
- 合格的医生的监督对于尽量减少不良事件至关重要.
相关概念视频
Parkinson's Disease: Treatment
257
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
257
Peripheral Nervous System: Ganglia and Nerves
1.8K
The Peripheral Nervous System (PNS) is a crucial component of the body's neural network, extending beyond the central nervous system (CNS) to bridge the gap between the CNS and the external environment. It encompasses nerves, ganglia, and sensory receptors.
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...
1.8K
Local Anesthetics: Differential Sensitivity of Nerve Fibers
812
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
812
Parkinson's Disease: Overview
527
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
527
Pathophysiology of Diabetes
920
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
920
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.3K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.3K


